Grand Brilliance Group Holdings Limited
HKSE: 8372.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Chong Chi Cheung
- Employees
- 50
- Headquarters
- Tsuen Wan, Hong Kong SAR China
- IPO year
- 2018
- Market cap
- HK$113.6M
- Website
- https://www.grandbrilliancegroup.com
Loading 8372…
Loading profile data…Frequently asked questions about 8372
What does Grand Brilliance Group Holdings Limited (8372.HK) do?
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical de...
Where does 8372.HK trade?
Grand Brilliance Group Holdings Limited (8372.HK) trades on the Hong Kong Stock Exchange.
What sector is 8372.HK in?
Grand Brilliance Group Holdings Limited (8372.HK) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Grand Brilliance Group Holdings Limited?
Chong Chi Cheung is the chief executive officer of Grand Brilliance Group Holdings Limited (8372.HK).
Where is Grand Brilliance Group Holdings Limited headquartered?
Grand Brilliance Group Holdings Limited is headquartered in Hong Kong SAR China.
Does 8372.HK pay a dividend?
Yes — Grand Brilliance Group Holdings Limited (8372.HK) paid a trailing twelve-month dividend of HKD 0.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 8372.HK go public?
Grand Brilliance Group Holdings Limited (8372.HK) completed its initial public offering in 2018.